TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral ...

The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to ...

Red Cross workers talk to a woman in Bunia, Democratic Republic of Congo, to raise awareness about Ebola on Monday. (Reuters) ...

After a prior misfire in demonstrating its protease inhibitor ensitrelvir’s potential as a COVID-19 treatment for U.S. patients, Shionogi has secured an FDA green light for the medicine in the ...

In 2023-24, the latest year for which data was available, of the 2,98,180 US students studying abroad, only 1,578 chose India ...

COVID-19 destroyed the world when it reared its head in 2020, killing millions of people across the world. Japan's Baba Vanga ...

During the volatile first quarter of 2026, the Lazard International Equity Portfolio rose 0.3% (net of fees), outperforming ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco ...

The number of foreign exchange students in Japan as of May 2025 hit a record high of 408,069, ahead of a government goal to ...

A wave of panic buying is causing municipally designated garbage bags to vanish from store shelves across Japan, forcing ...

Dozens of officials will patrol world-famous Shibuya as Japan responds to the impacts of overtourism.

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...